Schrodinger Inc
NASDAQ:SDGR

Watchlist Manager
Schrodinger Inc Logo
Schrodinger Inc
NASDAQ:SDGR
Watchlist
Price: 19.73 USD -0.15% Market Closed
Market Cap: 1.4B USD
Have any thoughts about
Schrodinger Inc?
Write Note
SDGR
/
Balance Sheet
/
Other Long-Term Assets

Schrodinger Inc
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Schrodinger Inc
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Schrodinger Inc
NASDAQ:SDGR
Other Long-Term Assets
$5.2m
CAGR 3-Years
9%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Veeva Systems Inc
NYSE:VEEV
Other Long-Term Assets
$401.3m
CAGR 3-Years
84%
CAGR 5-Years
52%
CAGR 10-Years
59%
Inspire Medical Systems Inc
NYSE:INSP
Other Long-Term Assets
$11m
CAGR 3-Years
280%
CAGR 5-Years
94%
CAGR 10-Years
N/A
Doximity Inc
NYSE:DOCS
Other Long-Term Assets
$46.5m
CAGR 3-Years
112%
CAGR 5-Years
102%
CAGR 10-Years
N/A
Omnicell Inc
NASDAQ:OMCL
Other Long-Term Assets
$104.8m
CAGR 3-Years
9%
CAGR 5-Years
6%
CAGR 10-Years
16%
W
Waystar Holding Corp
NASDAQ:WAY
Other Long-Term Assets
$72.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Schrodinger Inc
Glance View

Market Cap
1.4B USD
Industry
Health Care

In the bustling realm of computational chemistry, Schrödinger Inc. has carved a unique niche, transforming the way pharmaceutical and biotechnology companies approach drug discovery. Founded in 1990, the company has become synonymous with innovation, leveraging powerful physics-based software platforms that simulate molecular interactions at an atomic level. By providing researchers with tools to predict the behavior of complex biological systems, Schrödinger effectively bridges the gap between traditional experimental methods and cutting-edge computational techniques. Their flagship product, the Schrödinger platform, is instrumental in accelerating the drug discovery process, allowing scientists to virtually test countless compounds before selecting the most promising candidates for laboratory synthesis and testing. This capability significantly reduces the time and cost involved in bringing new drugs to market, providing tremendous value to its clients in the pharmaceutical industry. Schrödinger's financial success stems from its diversified business model, which includes software licensing, collaborative research and development projects, and, interestingly, strategic investments in biotech firms. The company licenses its software to a broad range of industries, from pharmaceuticals to materials science, generating a steady stream of revenue. Meanwhile, their collaborative projects enable Schrödinger to participate in revenue sharing or milestone payments based on the compounds developed using their technology. Additionally, by investing in biotech companies utilizing their software, Schrödinger not only fosters innovation but also stands to gain financially from any commercial success. This multifaceted approach not only secures their leadership in the industry but also ensures a robust growth trajectory, as they continue to expand the horizons of computational science.

SDGR Intrinsic Value
15 USD
Overvaluation 24%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Schrodinger Inc's Other Long-Term Assets?
Other Long-Term Assets
5.2m USD

Based on the financial report for Sep 30, 2024, Schrodinger Inc's Other Long-Term Assets amounts to 5.2m USD.

What is Schrodinger Inc's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
21%

Over the last year, the Other Long-Term Assets growth was -30%. The average annual Other Long-Term Assets growth rates for Schrodinger Inc have been 9% over the past three years , 21% over the past five years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.